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Introduction
As a consequence of nosocomial infection in the late 1980's, a relatively large and geographically concentrated number of HIV-infected young adults now live in Constanţa, Romania, and receive support services from the Baylor Black Sea Foundation (BBSF) via a public-private partnership. This population is representative of the HIV/AIDS epidemic in Romania, where adolescents and young adults represent 70% of the total known population living with HIV/AIDS and are long-term survivors (Buzducea, Lazǎr, & Mardare, 2010) . The transition to adulthood raises specific issues of medication adherence due to the shift from carer-managed adherence to selfmanagement. These issues are particularly important for HIV treatment due to its low tolerance for non-adherence (Conway, 2007) . Little research, however, has been conducted so far on adherence to HIV medication in Romania and no validated instruments exist for this population. Perceived treatment-related barriers may predict low adherence in people living with a chronic illness (Remor, 2011) , but their specific content and relationships with adherence behaviours and health status might vary substantially across sociocultural contexts, requiring careful investigation in new settings (Ware, Wyatt, & Bangsberg, 2006) .
To begin investigating adherence in this population, we translated and adapted a short measure of ARV adherence: the CEAT-VIH ("Cuestionario para la Evaluación de la Adhesión al Tratamiento Antirretroviral en Personas con Infección por VIH y Sida" in original, Remor, 2002a Remor, , 2002b Remor, , 2008 . We subsequently conducted a crosssectional survey on BBSF service users to examine the psychometric properties of the adapted CEAT-VIH, and to investigate the relations between self-reported adherence behaviours and psychological barriers as measured by this questionnaire, and established indicators of adherence and health status. We expected CEAT-VIH to show good psychometric properties and its scores to be significantly associated with pill count, doctor's assessment of patient's adherence, and viral load. The remaining analyses were exploratory and aimed at identifying associations relevant for future research and clinical practice.
Methods

Sample
A random sample of 312 patient records was extracted from the BBSF database ( Figure 1 ) and checked against inclusion criteria: aged 18-25, HIV+ status, currently receiving ARV therapy, likely to remain in the care of BBSF for the next year, no psychological or psychiatric issues that warrant urgent intervention, and no resistance to current treatment. The eligible patients (207) were invited to participate during their next scheduled visit; 184 patients gave written informed consent and underwent study procedures. Twenty-two patients did not complete the study (e.g. abandoned therapy, death, moved abroad, withdrawal).
______________________
Insert Figure 1 about here
______________________
Measures and procedures
The CEAT-VIH 2 was used to measure self-reported ARV adherence behaviours and barriers; it is a 20-item patient-reported outcome instrument developed and validated in Spain, and subsequently validated in Brazil (Remor, Milner-Moskovics, & Preussler, 2007) , Colombia and Mexico (Remor, 2008) , Portugal (Reis, Lencastre, Guerra, & Remor, 2009), and Peru (Tafur-Valderrama, Ortiz, Alfaro, García-Jiménez, & Faus, 2008) . It understands adherence as a multifaceted and complex behaviour;
items target behavioural indicators and determinants of adherence: antecedents of non-adherence behaviours, doctor-patient interaction, beliefs regarding adherencerelated effort, time, degree of difficulty, self-efficacy and outcome expectations, side effects intensity, treatment knowledge, satisfaction, improvements in health, and strategies to remember taking medication. Most items have a 5-point Likert scale response format, with one item on a 3-point scale and 2 dichotomous items (Appendix 1).
The CEAT-VIH adaptation included back-translation (Maneesriwongul & Dixon, 2004) , examination of source language and back-translated versions regarding comparability of language and similarity of interpretability (Sperber, 2004) , and piloting via cognitive interviews. A professional translator first translated the questionnaire from Spanish to Romanian; a different professional translator then translated back to Spanish. To identify problem-items, three fluent source-language speakers (two translators and one researcher, E. R.) compared the original and backtranslated items regarding the formal similarity of sentences and the degree to which they might lead to the same response, using 7-point Likert scales (from 'extremely similar' to 'not at all similar'). Three items received mean scores above 2.5 (threshold recommended for item revision) and were revised.
We conducted face-to-face cognitive interviews with 11 service users (convenience sample; aged 18-22 years; 5-14 years of education). Participants responded to the questionnaire and assessed item clarity and comprehensibility, suggested rephrasing problematic items, and made additional comments. Numerous words were reported as difficult to understand (e.g., "qualify", "effort", "strategy"); twelve items were simplified (e.g. "How do you qualify the relationship with your doctor?" became "How do you get along with your doctor?"). Moreover, the words "medicines", "medication", "antiretrovirals", "treatment" were replaced with "pills", reported as most comprehensible. Two items (regarding the patient's perception of the effort required for and difficulty of maintaining adherence) were interpreted similarly by respondents, and were thus simplified to the same format ("How hard is it for you to take your pills?"), but with different response formats.
Pill count and the doctor's assessment were also used to measure adherence.
Pill count was computed as a percentage: (total number of tablets dispensed -number of tablets returned)/ total number of tablets dispensed ×100. Three clinically relevant ordered categories were recorded: >95% (good adherence), 65-95% (high risk of developing resistance), and <65% (very poor adherence, unlikely to develop resistance due to low drug levels). During their next scheduled visit to the clinic for obtaining refills, participants were instructed to use only pills from their current refill.
BBSF community social workers made unannounced home visits within two weeks and counted the number of pills in their pill boxes. The physicians consulting the participating patients were asked to complete a global adherence evaluation for each patient (3 ordered categories: <80%, 80-95%, and >95%). Viral load was recorded dichotomously based on the standard Romanian clinical criterion as detectable (≥400 copies/ml) versus undetectable (<400 copies/ml).
Sociodemographic and treatment-related variables were included from patient files: age, gender, location (dichotomous: rural versus urban), educational level (3 ordered categories: less than high school; high school or equivalent; more than high school), educational history (dichotomous: abandoned versus ongoing/completed), number of children, ARV treatment duration and current ARV treatment complexity (number of ARV pills taken per day). 
Statistical analyses
Data analysis was performed using R (R Development Core Team, 2009).
Psychometric properties were examined within classical test theory (reliability and external criterion validity), which was also used for previous CEAT-VIH validation studies. Item analyses were performed to identify areas of questionnaire improvement.
Associations with sociodemographic variables were also examined. Since no theoretical claims exist regarding the structure of self-reported adherence in relation to CEAT-VIH, structural validity was not examined (e.g. factor analysis). 
Results
Participants
From the 162 participants aged 18-24, 52.5% were female, 49.4% from urban areas, 90.7% unemployed (of which 26.5% currently studying), 13.6% with children. The majority were either currently studying or had finalized their education level (66%);
44.4% had an education level below high school, 40.7% were attending or had attended high school or equivalent, while 14.9% had a higher education level.
Treatment duration ranged from 1 to 22 years (mode 11 years). Participants took between 2 and 11 ARV pills daily (mode 6 pills). Non-detectable viral load was identified for 46.3% of participants. Pill count indicated good adherence levels (i.e., >95%) for 59.9% of participants, while doctors considered only 36.4% participants adherent above 95% (Table 1) . The most frequently used strategy to remember taking pills was using phone alarms (n=20), followed by being reminded by others (family, friends, partners; n=16), associating medication with food intake (n=5) and placing medication in a visible location (n=2).
______________________
Insert Most items were skewed towards reporting adherence (Appendix 1). Only two items had nonsignificant item-total correlations (reporting medication labels and use of strategies to remember taking pills). None of the items would considerably improve the reliability if deleted, therefore no items were excluded in this analysis (questionnaire improvement will be considered consistently for all CEAT-VIH versions in a dedicated study).
Psychological barriers to adherence
We examined the associations ( 
______________________
Insert Table 2 about here ______________________ Most items were significantly associated with self-reported adherence, except items addressing health status (10), the doctor-patient relationship (6 and 13), information and use of strategies (8 and 20). The latter four were unrelated to any adherence indicators. Doctors' assessments showed a pattern of associations similar to self-reported adherence, except a lack of association with patient's outcome expectations (9). Thus, adherence behaviours (according to both self-reports and doctor's assessment) seemed to be particularly at risk when the patients felt physically better or worse or emotionally distressed, if they perceived adherence as difficult and requiring time and effort, if they had less confidence in their ability to perform these behaviours, if they felt less satisfied with their treatment, and if they experienced more side effects. Pill count was significantly associated only with perceived selfefficacy (11), which was also related with viral load, together with the perceived difficulty of adherence and side effects (7, 15, 18) and the health status-related items (10 and 14). However effect sizes were generally small to medium, and correcting for multiple testing resulted in a lower number of significant associations (Table 2) .
Discussion
Our findings contribute to the existing literature in two important ways. First, they represent a more detailed characterisation of adherence behaviours and determinants in Romanian HIV-infected young adults, adding to the limited information on this population and representing a starting point in developing behaviour change interventions. Second, they indicate that the translation and adaptation of the CEAT-5 Item no. 5 had low item-total correlation (.18, p=.03) and low correlations with the other 4 items (-.04 to .13), reducing the subscale's Cronbach's α to .55. It was therefore excluded from this analysis.
VIH to Romanian produced a questionnaire with reliability and validity comparable to versions in other languages and countries (Reis et al., 2009; Remor, 2002a Remor, , 2002b Remor et al., 2007; Tafur-Valderrama et al., 2008) Our sample had higher self-reported adherence levels relative to the original Spanish sample, as indicated by the difference in cut-off scores for strict adherence (84 versus 79). Although other studies assessing adolescents and young adults have reported higher adherence levels (e.g. Belzer, Fuchs, Luftman, & Tucker, 1999) , this may have been due partly to social desirability and sampling, especially excluding patients who abandoned or were resistant to current treatment. Nevertheless, pill count and doctor's assessments indicate that numerous participants were nonadherent, which highlights the need for improving current services.
Only 8% of participants could be considered adherent according to all three measures, suggesting that each indicator constructs adherence differently. While CEAT-VIH classifies strict self-reported adherence relative to the sample (scores higher than 85% of the study participants), pill count computes adherence as medication use relative to the quantity prescribed, and doctor's assessment is a global subjective rating which considers various patient behaviours and medical data. These differences highlight the multifaceted nature of adherence and the need to assess it on multiple levels (see Bangsberg, 2008 , for a comparative analysis of adherence assessment methods).
The differences between the adherence and health status indicators are also revealed by their different patterns of association with adherence barriers. Consistent with previous studies (e.g., Segeral et al., 2010; Wiener, Riekert, Ryder, & Wood, 2004) , self-reported adherence and doctors' assessments were associated with most barriers, suggesting that both patients' and doctors' judgements of adherence may rely partly on patients' reports of their perceptions of these barriers. The correlation between perceptions of treatment efficacy and viral load could be partly due to respondents assessing treatment performance also based on current health status indicators, including symptoms and results of medical tests. The associations of viral load and pill count with patient's perceptions of self-efficacy, and of viral load with perceptions of adherence difficulty and side effects support established health behaviour theories regarding the role of behavioural and control beliefs in guiding behaviour. For example, they support the role of perceived behavioural control (selfefficacy) and attitudes toward behaviour (negative appraisals of difficulty and harm) in predicting adherence, as stipulated in the Theory of Planned Behaviour (Ajzen, 1991) . However causal relations are likely bidirectional and need to be further explored in longitudinal research.
Most barriers account for a significant proportion of variance in adherence behaviours, highlighting the importance of focusing counselling interventions on common difficulties (e.g., changes in physical and emotional states as antecedents of non-adherence, perceived adherence self-efficacy, concerns regarding difficulty, time, effort, side effects). However the low to medium effect sizes of these associations (Table 2) indicate that most adherence barriers have minor contributions to adherence behaviours at group level. Indeed, when controlling for multiple comparisons, fewer barriers show significant associations and only to self-reported and doctor-assessed adherence. This exposes the need to also identify difficulties relevant to individual patients when providing adherence support.
Notably, knowledge of medication labels and use of strategies to remember taking pills were unrelated to adherence or health status indicators, suggesting that these items may be deleted or reviewed to improve validity. This may equally reflect the lower relevance of these two aspects for adherence in our group. Similarly, sociodemographic factors had a minor impact on self-reported and doctor-assessed adherence, and no impact on actual pill use. However, the high unemployment rate (90.7%) reveals a difficult socioeconomic situation. Although the impact of employment status on adherence is not consistently supported in the literature, unemployment may impede adherence via the stress of job insecurity and lower control over daily schedule (Falagas, Zarkadoulia, Pliatsika, & Panos, 2008 ). This suggests a need for including services such as vocational counselling and training within the psychosocial support programmes offered.
The results of this study should be considered in light of its limitations. First, the sample size was reduced by logistical restrictions aimed at minimizing interference with clinical care, and thus limited our ability to test associations with smaller effect sizes while controlling adequately for Type I errors. Second, given the brevity of the CEAT-VIH, these results certainly do not exhaust the range of barriers to adherence in this population. Therefore it would need to be complemented with additional assessments in clinical practice.
Conclusion
Our results suggest several avenues of investigation regarding the psychological barriers to ARV adherence in Romanian young adults. They indicate that low selfreported adherence is more likely when patients feel physically better or worse or emotionally distressed, and if they perceive adherence as difficult and requiring time and effort, have less confidence in their ability to adhere to the medication schedule, feel less satisfied with their treatment, experience more side effects and have lower outcome expectations. These relationships may provide a good starting point for investigating ARV adherence in this population.
Moreover, this study represents an important advancement towards reliable adherence measurement for both research and clinical practice with Romanian young adults. While the total score can be considered a good overall indicator of treatment adherence, examining responses to individual items may prove useful for identifying specific targets for intervention. 
